A novel type of protein nanoparticle vaccine formulation containing influenza proteins and adjuvant to boost immune responses has provided complete protection against influenza viral challenges, according to a new study published by researchers in the Institute for Biomedical Sciences at Georgia State University.
The researchers developed a novel type of core/shell protein nanoparticle consisting of influenza nucleoprotein as the core and NA1-M2e or NA2-M2e surface proteins as the coating antigens. In the new nanoparticle fabrication, the surface protein coating can be precisely controlled and any excessive coating proteins can be recovered for reuse.
Thus, nanoparticle quality and yield are improved significantly. Mice were intramuscularly or intranasally vaccinated with the resulting protein nanoparticles with and without immune-stimulating complexes as adjuvants to determine the immune response and protective efficiency against influenza viral infections.
“We found that the novel protein nanoparticles combined with the adjuvants could induce significantly improved mucosal immune responses and the accumulation of lung resident memory cells in the local respiratory tracts, providing complete protection against influenza viral infections,” said Dr. Wandi Zhu, first author of the study and a research assistant professor in the Institute for Biomedical Sciences at Georgia State.
Influenza A virus is one of the most threatening respiratory pathogens and can cause severe morbidity, mortality and heavy economic burdens, especially in flu epidemics or pandemics. While vaccination is effective in preventing or reducing viral infections during annual flu seasons, the selection of vaccine strains depends on circulating viral surveillance and prediction.
Mismatched strains could significantly impair vaccine efficiency. Also, the production of the current quadrivalent influenza vaccine is time-consuming. New vaccine technologies are needed to easily manufacture a universal influenza vaccine. The researchers have focused their work on developing different types of protein nanoparticle vaccines against both influenza A and influenza B viral infections.
“The epidemics caused by the influenza virus seriously threaten public health and the economy,” said Dr. Baozhong Wang, senior author of the study and Distinguished University Professor in the Institute for Biomedical Sciences at Georgia State. “Adding appropriate adjuvants to improve immunogenicity and finding effective mucosal vaccines to combat respiratory infection at the portal of virus entry are important strategies to boost protection.”
Adjuvanted protein nanoparticles could improve strong systemic and mucosal immune responses conferring protection in different immunization routes. This work highlights the importance of applying adjuvants in mucosal vaccine formulations. The adjuvanted protein nanoparticles can be used as mucosal vaccines alone or in combination with other vaccines to improve mucosal immunity and protection in the future, Zhu explained.
“The new surface protein coating is a more controlled and efficient fabrication method than our previous process, significantly increasing the utilization of the initial proteins,” Zhu said. “The technique could be used to develop universal influenza vaccines consisting of influenza antigens from influenza A and influenza B viruses. The combination of the vaccine with appropriate adjuvants will be promising mucosal vaccine candidates.”

News
Polaritons open up a new lane on the semiconductor highway
On the highway of heat transfer, thermal energy is moved by way of quantum particles called phonons. But at the nanoscale of today's most cutting-edge semiconductors, those phonons don't remove enough heat. That's why [...]
EU seeks agreement on world’s first AI law
The European Union will seek to thrash out an agreement on sweeping rules to regulate artificial intelligence on Wednesday, following months of difficult negotiations in particular on how to monitor generative AI applications like [...]
Lightning sparks scientists’ design of ultraviolet-C device for food sanitization
Scientists at the University of Illinois Urbana-Champaign have developed a portable, self-powered ultraviolet-C device called the Tribo-sanitizer that can inactivate two of the bacteria responsible for many foodborne illnesses and deaths. The Tribo-sanitizer's UVC [...]
3D Eye Scans Emerge as a Crucial Tool in Combating Kidney Disease
A new study indicates that 3D retinal scans could revolutionize the early detection and monitoring of kidney disease, offering a non-invasive and efficient diagnostic tool. 3D eye scans can reveal vital clues about kidney [...]
Researchers develop a blood test to identify individuals at risk of developing Parkinson’s disease
Research carried out at Oxford's Nuffield Department of Clinical Neurosciences has led to the development of a new blood-based test to identify the pathology that triggers Parkinson's disease before the main symptoms occur. This [...]
“Challenging the Paradigm” – Scientists Develop New Approach To Stop Cancer Growth
Biochemists at Case Western Reserve are concentrating on the degradation of a key protein that drives cancer; represents a major shift in research. Biochemical researchers at Case Western Reserve University have discovered a a new function [...]
Researcher develops a chatbot with an expertise in nanomaterials
A researcher has just finished writing a scientific paper. She knows her work could benefit from another perspective. Did she overlook something? Or perhaps there's an application of her research she hadn't thought of. [...]
Research shows human behavior guided by fast changes in dopamine levels
What happens in the human brain when we learn from positive and negative experiences? To help answer that question and better understand decision-making and human behavior, scientists are studying dopamine. Dopamine is a neurotransmitter [...]
Tiny robots made from human cells heal damaged tissue
The ‘anthrobots’ were able to repair a scratch in a layer of neurons in the lab. Scientists have developed tiny robots made of human cells that are able to repair damaged neural tissue1. The [...]
Antimicrobial Resistance – A Global Concern
Key facts Antimicrobial resistance (AMR) is one of the top global public health and development threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to [...]
Advancing Pancreatic Cancer Treatment with Nanoparticle-Based Chemotherapy
Pancreatic cancer, a particularly lethal form of cancer and the fourth leading cause of cancer-related deaths in the western world, often remains undiagnosed until its advanced stages due to a lack of early symptoms. [...]
The ‘jigglings and wigglings of atoms’ reveal key aspects of COVID-19 virulence evolution
Richard Feynman famously stated, "Everything that living things do can be understood in terms of the jigglings and wigglings of atoms." This week, Nature Nanotechnology features a study that sheds new light on the evolution of the coronavirus [...]
AI system self-organizes to develop features of brains of complex organisms
Cambridge scientists have shown that placing physical constraints on an artificially-intelligent system—in much the same way that the human brain has to develop and operate within physical and biological constraints—allows it to develop features [...]
How Blind People Recognize Faces via Sound
Summary: A new study reveals that people who are blind can recognize faces using auditory patterns processed by the fusiform face area, a brain region crucial for face processing in sighted individuals. The study employed [...]
Treating tumors with engineered dendritic cells
Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor's antigenic makeup. The new results may pave the way [...]
Networking nano-biosensors for wireless communication in the blood
Biological computing machines, such as micro and nano-implants that can collect important information inside the human body, are transforming medicine. Yet, networking them for communication has proven challenging. Now, a global team, including EPFL [...]